LifeMD, Inc.

LFMD Healthcare Health Information Services

LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.55%, EPS fell 166.7% and free cash flow fell 247.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

2.34 0.12 −4.88%
Market cap
$118.6M
P/E
0.0×
Fwd P/E
−17.9×
Dividend yield
—
F-score
6/9
Altman Z
−0.02
Beneish M
−3.67
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 8 6 4

+8 more TTM periods

ROE
(69.60%) 34.95% 144.18% 913.95%
ROA
(4.35%) 3.56% 15.35% (17.07%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
116.73% 58.54% 88.55% 90.99%
Average Days of Receivables
21.44 18.61 17.50 20.23
Free Cash Flow per Share
(0.38) (0.08) (0.03) 0.07
Free Cash Flow
(18.28) (3.91) (1.24) 3.08
Capital Expenditures
(8.37) (9.57) (9.52) (9.55)
Other line items
Cash ROIC
(55.20%) (7.91%) (2.07%) 11.35%
Accounts Receivable Turnover
20.62 19.29 19.64 21.82
Accounts Payable Turnover
1.13 1.37 2.21 1.65
Inventory Turnover
7.72 8.30 9.95 9.60
Average Days of Payables
276.72 309.89 186.34 244.56
Days of Inventory on Hand
45.05 45.47 36.53 42.93
Tax Rate
0.00 0.00 0.06 0.09
Research and Development Expense of Revenue
3.78% 3.77% 3.79% 3.77%
Selling, General and Administrative Expense of Revenue
82.23% 78.85% 74.21% 70.86%
Share Based Compensation of Revenue
4.22% 4.86% 5.41% 6.56%
Interest Coverage
— (10.25) (3.79) (4.72)
Operating CF/Net income
3.41 2.21 0.74 (1.07)
Depreciation/Fixed assets
3.88 3.43 3.09 3.12
Capex/Depreciation
(1.06) (1.24) (1.26) (1.19)
Revenue per Share
4.01 4.08 4.30 3.61
Operating CF per Share
(0.21) 0.12 0.18 0.27
Capex per Share
(0.18) (0.20) (0.21) (0.21)
Capex to Sales
0.04 0.05 0.05 0.06

Fold the line items

Columns are period end dates